Kenya

in page functions
[French]
Total population (2015) 46,050,148
Birth cohort (2015) 1,571,032
Surviving Infants (surviving to 1 year per year, 2015) 1,492,311
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 36/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 49/1000
World Bank Index, IDA (2012) 3.79
Gross Nation Income (per capita US$, 2014) 1,280
Co-financing status (2016) Preparatory transition
No. of districts/territories (2014) 286

Gavi support for Kenya

Type of support

Approvals

2001-2020 (US$)
(30 Nov 2015)

Commitments

2001-2020 (US$)
(30 Nov 2015)

Disbursements

2000-2015 (US$)
(30 Nov 2015)

% Disbursed

(30 Nov 2015)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Cash Support (CASHSUPP) $145,000 $170,000 $145,000 100%
Health system strengthening (HSS 1) $9,903,000 $9,903,000 $9,903,000 100%
HPV Demo (NVS) $261,749 $261,749 $261,749 100%
Immunisation services support (ISS) $6,420,320 $6,420,320 $4,217,180 66%
Injection safety support (INS) $1,129,963 $1,129,963 $1,129,963 100%
IPV (NVS) $3,010,500 $4,791,000 $2,160,858 72%
Measles-Rubella (NVS) $14,893,000 $14,893,000 $13,980,455 94%
MR - Operational costs (OPC) $12,332,500 $12,332,500 $12,332,500 100%
Penta (NVS) $165,783,760 $165,783,760 $159,699,435 96%
Pneumo (NVS) $175,491,253 $175,491,253 $171,152,827 98%
Rotavirus (NVS) $17,848,500 $17,848,500 $12,135,023 68%
Vaccine Introduction Grant (VIG) $4,282,500 $4,282,500 $4,282,500 100%
Yellow Fever (NVS) $458,910 $458,910 $407,413 89%
Total $411,960,955 $413,766,455 $391,807,902

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Kenya DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2014)

Grade of confidence


N/A
DTP3 - Official country estimates (2014) 81%
M:F sex ratio at birth (2015) 1.03
Household survey: DTP3 coverage for male (2009) 82.90%
Household survey: DTP3 coverage for female (2009) 89.80%
Household survey: Last DTP3 survey (2009) 86%
% districts achieving > 80% DTP3 coverage (2014) 47%
% districts achieving < 50% DTP3 coverage (2014) 10%
MCV WHO/UNICEF estimates (2014) 79%

Breakdown of support

Non-vaccine support Vaccine support
8% 92%
$32,010,142 $359,797,756

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Kenya

05 February 2016

Pentavalent vaccine

Study shows near elimination of Hib disease in Kilifi region of Kenya after introduction of vaccine

Welcome Trust and Gavi funded research also shows Hib booster not needed for long-term protection.

17 July 2015

India pentavalent scale-up 2014

New coverage figures show more children than ever being reached with immunisation in poorest countries

Coverage trends heading in right direction but major differences remain between countries.

25 June 2015

Pneumococcal vaccine impact study in Kenya

Video showing Kenya’s efforts to tackle pneumococcal disease and highlighting pneumococcal vaccine impact study at the Wellcome Trust centre KEMRI at Kilifi.

close icon

modal window here